1. Novel monoclonal antibodies against house dust mite allergen Der p 21 and their application to analyze allergen extracts.
- Author
-
Rudokas V, Silimavicius L, Kucinskaite-Kodze I, Sliziene A, Pleckaityte M, and Zvirbliene A
- Subjects
- Animals, Arthropod Proteins immunology, Mice, Allergens immunology, Allergens analysis, Blotting, Western, Pyroglyphidae immunology, Mice, Inbred BALB C, Antibodies, Monoclonal immunology, Antibodies, Monoclonal isolation & purification, Antigens, Dermatophagoides immunology, Enzyme-Linked Immunosorbent Assay methods, Recombinant Proteins immunology
- Abstract
Background: Allergen extracts and recombinant allergens are used in allergy diagnostics and immunotherapy. Since allergen extracts from different manufacturers lack proper standardization regarding their composition, monoclonal antibodies (MAbs) against specific allergen components can be used for their identification and quantification in allergen extracts. This study aimed to generate MAbs against allergen Der p 21 of Dermatophagoides pteronyssinus for the analysis of allergen extracts., Methods: Recombinant Der p 21 was expressed in E. coli and purified using affinity chromatography. MAbs against Der p 21 were generated using hybridoma technology. House dust mite (HDM) allergen extracts were analyzed using the newly developed sandwich enzyme-linked immunosorbent assay, Western blotting and microarray immunoassay., Results: MAbs raised against recombinant Der p 21 were characterized in detail and proven to be reactive with natural Der p 21. Highly specific sandwich enzyme-linked immunosorbent assay for the quantification of Der p 21 was developed and optimized. The allergen was detected and its concentration was determined in only three of six analyzed HDM allergen extracts from different manufacturers., Conclusion: HDM analysis by MAb-based immunoassays shows their differences in allergen composition. The results demonstrate the importance of allergen-specific MAbs as a tool for the characterization of allergen extracts and the need for their appropriate standardization before their use for allergy diagnostics or immunotherapy., Competing Interests: Laimis Silimavicius is employed by UAB Imunodiagnostika, the Lithuanian company that specializes in the development of microarray-based assays and allergy in vitro diagnostics., (©2024 Rudokas et al.)
- Published
- 2024
- Full Text
- View/download PDF